ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "primary care"

  • Abstract Number: 0134 • ACR Convergence 2024

    Use of Oral Contraceptives in Females with Rheumatoid Arthritis Is Not Associated with an Increased Risk of Venous Thromboembolism: United Kingdom-population Based Study

    James Galloway1, Victoria Basey2, Anna Barkaway3, Simon de Lusignan4 and Maya H. Buch5, 1Centre for Rheumatic Diseases, King's College London, London, United Kingdom, 2Pfizer UK, Tadworth, United Kingdom, 3Pfizer, Tadworth, United Kingdom, 4Royal College of General Practitioners Research and Surveillance Centre, Oxford, United Kingdom, 5Division of Musculoskeletal & Dermatological Sciences, University of Manchester, and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom

    Background/Purpose: While the use of oral contraceptives in females with immune mediated inflammatory diseases such as rheumatoid arthritis (RA) is acknowledged as a risk factor…
  • Abstract Number: 0135 • ACR Convergence 2024

    Rheumatoid Arthritis Associated Risk of Venous Thromboembolism Is Not Dependent on Disease Duration: United Kingdom Based Population Study

    James Galloway1, Victoria Basey2, Saqib Rana3, Simon de Lusignan4 and Maya H. Buch5, 1Centre for Rheumatic Diseases, King's College London, London, United Kingdom, 2Pfizer UK, Tadworth, United Kingdom, 3Pfizer, Tadworth, United Kingdom, 4Royal College of General Practitioners Research and Surveillance Centre, Oxford, United Kingdom, 5Division of Musculoskeletal & Dermatological Sciences, University of Manchester, and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom

    Background/Purpose: Risk of venous thromboembolism (VTE) is higher in patients with rheumatoid arthritis (RA) compared to the general population; however whether this risk changes with…
  • Abstract Number: 0191 • ACR Convergence 2024

    Beyond the Symptoms: Exploring Cognitive Bias in Lupus Diagnosis Within Primary Care

    Alyssa Howren1, Quan Le Tran1, Sadaf Sediqi1, Saadiya Hawa2, Eleni Linos1, Titilola Falasinnu3, Yashaar Chaichian1 and Julia Simard1, 1Stanford School of Medicine, Stanford, CA, 2Weiss Memorial Hospital, Chicago, IL, 3Stanford School of Medicine, Palo Alto, CA

    Background/Purpose: Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune rheumatic disease whose prognosis varies by race and sex. To understand whether the cognitive processes of…
  • Abstract Number: 0206 • ACR Convergence 2024

    Urate Lowering Therapy to Acute Treatment Ratio (ULTrA) Index – a Novel Quality Indicator Associated with Reduced Hospital Admissions for Gout

    May Shuen Tang, Frank Sen Hee Tay, Amelia Santosa, Shikha Kumari, Pamela Lim, Htet Htet Aung, Su Zin Thinn, Peter Cheung and Manjari Lahiri, National University Hospital, Singapore, Singapore

    Background/Purpose: Gout is sub-optimally managed with under-prescribed urate lowering therapy (ULT) leading to frequent flares, increased healthcare utilization and cost.To study the burden of gout…
  • Abstract Number: 0352 • ACR Convergence 2024

    Fast-tracking Axial Spondyloarthritis Diagnosis: A Novel Approach to Public Health Advocacy and Awareness

    Joe Eddison, National Axial Spondyloarthritis Society, London, United Kingdom

    Background/Purpose: The Act on Axial SpA campaign is dedicated to minimising the lengthy 8.5-year delay in diagnosing axial spondyloarthritis (axial SpA) by implementing a pioneering…
  • Abstract Number: 0547 • ACR Convergence 2024

    EspANDE Project: Improvement of Primary Care-Rheumatology Coordination in Spondyloarthritis in a Health Area in Northern Spain

    Julio Sánchez-Martín1, Cristina Martinez-Dubois2, Javier Rueda Gotor3, Gabriel Pinedo-Lopez2, Alvaro Perez-Martin2, Roberto Gonzalez-Santamaria2, Belén Atienza-Mateo4, Vanesa Calvo-Rio5, Inigo Gonzalez-Mazon6, Natalia Palmou Fontana4, Enriqueta Peiro-Callizo2, Diana Prieto-Peña4, Lara Sanchez Bilbao7, Fernando Lopez-Gutierrez8 and Ricardo Blanco-Alonso9, 1Hospital Universitario 12 de Octubre, Madrid, Spain, 2Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain, Santander, Cantabria, Spain, 3Hospital Sierrallana, Torrelavega, Cantabria, Spain, 4Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Cantabria, Spain, 5Valdecilla Hospital, Santander, Cantabria, Spain, 6H. U. Marques de Valdecilla, Santander, Cantabria, Spain, 7Rheumatology and Ophthalmology. Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain, 8Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Cantabria, Spain, 9Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Spain

    Background/Purpose: Spondyloarthritis (SpA) constitutes a diverse set of inflammatory rheumatic diseases with a prevalence of 1.9% in the general population. Diagnostic delay, identified as a…
  • Abstract Number: 1079 • ACR Convergence 2024

    Early Recognition of Myositis: Time Correlation Between Transaminases and Inflammatory Myopathy in a Community-Based Rheumatology Practice

    Anjali nidhaan, Shannon Iriza, Abbie West, Michael martin and Gauri Pethe, prisma health, columbia, SC

    Background/Purpose: Recognizing muscle breakdown as a potential cause of elevated transaminases is crucial in the primary care setting to facilitate early referral to rheumatology for…
  • Abstract Number: 0140 • ACR Convergence 2023

    Extent of Recording of 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus in a UK Healthcare Database

    Jessica Ellis1, Anita McGrogan2, Neil McHugh2, Ben Mulhearn3, Eleanor Korendowych4, John Pauling5, Ian Bruce6, Jenny Humphreys7 and Sarah Skeoch1, 1University of Bath; Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, 2University of Bath, Bath, United Kingdom, 3Royal United Hospital Bath | University of Bath, Bath, United Kingdom, 4Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, 5North Bristol NHS Trust, Bristol, United Kingdom, 6University of Manchester, Manchester, United Kingdom, 7University of Manchester, Stockport, United Kingdom

    Background/Purpose: The 2019 EULAR/ACR Classification Criteria allow classification of patients with systemic lupus erythematosus (SLE) for research. They reflect updates in current understanding of SLE…
  • Abstract Number: 1120 • ACR Convergence 2023

    Target Serum Urate Levels, Recurrent Gout Flare Rates, and Gout-Primary Hospitalizations: Nationwide Prospective Cohort Study of 3,613 Gout Patients

    Natalie McCormick1, Chio Yokose2, Gregory Challener1, Amit Joshi3, Sruthi Tanikella1 and Hyon K. Choi4, 1Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital, Waltham, MA, 3Channing Division of Network Medicine, Boston, MA, 4Massachusetts General Hospital and Harvard Medical School, Lexington, MA

    Background/Purpose: Despite rheumatology guidelines' emphasis on treat-to-target-serum-urate (SU) levels (<6 or <5 mg/dL, urate crystal sub-saturation points), this pathophysiology-based recommendation is not accepted in primary…
  • Abstract Number: 1351 • ACR Convergence 2023

    HPV Vaccination in Adolescent and Young Adult Patients Seen in an Academic Rheumatology Center

    Caroline Siegel1, Lauren Robinson1, Deanna Jannat-Khah1, Avi Mikhaylov1, Nancy Pan1 and Lisa Sammaritano2, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: Adolescent and young adults (AYAs) with rheumatic disease (RD) may face disproportionate risk of HPV and associated cancers due to immune dysregulation, immunosuppression and…
  • Abstract Number: 1819 • ACR Convergence 2023

    Clinical Indications Associated with New Opioid Use for Pain Management in the United Kingdom Using National Primary Care Data

    Max Lyon, Carlos Ramirez Medina, Elinor Davies and Meghna Jani, Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom

    Background/Purpose: Prescription opioids for non-cancer pain in the UK have increased considerably over the past two decades, alongside a rise in associated harms. Despite the…
  • Abstract Number: 1848 • ACR Convergence 2023

    Demographic and Clinical Factors Associated with HPV Vaccination in Young Adults with Rheumatic Disease

    Caroline Siegel1, Lauren Robinson1, Deanna Jannat-Khah1, Avi Mikhaylov1, Nancy Pan1 and Lisa Sammaritano2, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: The HPV vaccine is safe and immunogenic in RD patients but uptake is suboptimal. We aimed to evaluate factors associated with HPV vaccination in…
  • Abstract Number: 1994 • ACR Convergence 2023

    How Is Paracetamol Prescribed in Low Back Pain and Osteoarthritis in France? Paracetamol Prescription Patterns in the Real-World General Practice

    Jasque Cittée1, Pierre Lemire2, Anna Annenkova3, Jean-Yves Milon3 and Serge Perrot4, 1University Paris-Est Créteil Val de Marne Department of General Medicine, Paris, France, 2IQVIA, Paris, France, 3UPSA, Rueil-Malmaison, France, 4Cochin Hospital, Université Paris Cité, INSERM U987, Paris, France

    Background/Purpose: Lower back pain (LBP) and osteoarthritis (OA) are the most frequent musculoskeletal disorders in the general population significantly impacting patients' quality of life. An…
  • Abstract Number: 2075 • ACR Convergence 2023

    The Impact of Rheumatology Fellow Initiated Curriculum Design on Resident Education

    Karen Kruzer1, Vincent Vertalino1, Nilson Tapia1, Andrew Long1, Amy Blatt2, Ummara Shah1 and Bethany Marston1, 1Department of Rheumatology, University of Rochester Medical Center, Rochester, NY, 2Department of Medicine, University of Rochester Medical Center, Rochester, NY

    Background/Purpose: Rheumatology fellows have a critical role as medical educators for residents and offer unique perspectives on patient care. Fellow scholarly activity is an ACGME…
  • Abstract Number: 1643 • ACR Convergence 2022

    Use of Oral Analgesics and Risk of Comorbidities in Osteoarthritis: Findings from Primary Care Settings in the UK

    Subhashisa Swain1, Carol Coupland2, Anne Kamps3, Jos Runhaar4, Andrea Dell ‘Isola5, Aleksandra Turkiewicz5, Danielle E Robinson1, Victoria Y Strauss1, Christian Mallen6, Chang-Fu Kuo7, Aliya Sarmanova8, Daniel Prieto Alhambra1, Martin Englund5, Sita Bierma-Zeinstra3, Michael Doherty2 and Weiya Zhang2, 1University of Oxford, Oxford, United Kingdom, 2University of Nottingham, Nottingham, United Kingdom, 3Erasmus University Medical Centre, Rotterdam, Netherlands, 4Erasmus Medical Center, Rotterdam, Netherlands, 5Lund University, Lund, Sweden, 6Keele University, Keele, United Kingdom, 7Chang Gung Memorial Hospital, Taoyuan, Taiwan, 8University of Bristol, Bristol, United Kingdom

    Background/Purpose: People with osteoarthritis (OA) often have multiple other conditions (comorbidities).Role of different oral analgesics on the development of comorbidities in people with OA have…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology